Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis

Por Croze, E, Yamaguchi, K D, Knappertz, V, Reder, A T, Salamon, H
Publicado em 2013

Lack of hemispheric dominance for consciousness in acute ischaemic stroke

Por Cucchiara, B, Kasner, S, Wolk, D, Lyden, P, Knappertz, V, Ashwood, T, Odergren, T, Nordlund, A
Publicado em 2003

Survival in MS: A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

Por Goodin, D.S., Reder, A.T., Ebers, G.C., Cutter, G., Kremenchutzky, M., Oger, J., Langdon, D., Rametta, M., Beckmann, K., DeSimone, T.M., Knappertz, V.
Publicado em 2012

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

Por Filippi, M., Rocca, M.A., Camesasca, F., Cook, S., O'Connor, P., Arnason, B.G.W., Kappos, L., Goodin, D., Jeffery, D., Hartung, H.-P., Comi, G., Wolinsky, J.S., Bogumil, T., Pohl, C., Beckmann, K., Sandbrink, R., Croze, E., Brown, C., DeSimone, T.M., Arnold, D.L., Cutter, G., Knappertz, V.
Publicado em 2011